Journal of Gastroenterology

, Volume 42, Issue 9, pp 730–736 | Cite as

Effectiveness of gene expression profiling for response prediction of rectal cancer to preoperative radiotherapy

  • Eiki Ojima
  • Yasuhiro Inoue
  • Chikao Miki
  • Masaki Mori
  • Masato Kusunoki
Alimentary Tract



Our aim was to determine whether the expression levels of specific genes could predict clinical radiosensitivity in human colorectal cancer.


Radioresistant colorectal cancer cell lines were established by repeated X-ray exposure (total, 100 Gy), and the gene expressions of the parent and radioresistant cell lines were compared in a microarray analysis. To verify the microarray data, we carried out a reverse transcriptase-polymerase chain reaction analysis of identified genes in clinical samples from 30 irradiated rectal cancer patients.


A comparison of the intensity data for the parent and three radioresistant cell lines revealed 17 upregulated and 142 downregulated genes in all radioresistant cell lines. Next, we focused on two upregulated genes, PTMA (prothymosin α) and EIF5a2 (eukaryotic translation initiation factor 5A), in the radioresistant cell lines. In clinical samples, the expression of PTMA was significantly higher in the minor effect group than in the major effect group (P = 0.004), but there were no significant differences in EIF5a2 expression between the two groups.


We identified radiation-related genes in colorectal cancer and demonstrated that PTMA may play an important role in radiosensitivity. Our findings suggest that PTMA may be a novel marker for predicting the effectiveness of radiotherapy in clinical cases.

Key words

radiation-related genes colorectal cancer PTMA (prothymosin α) 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    NIH consensus conference1990Adjuvant therapy for patients with colon and rectal cancerJAMA264144450CrossRefGoogle Scholar
  2. 2.
    Spitz, FR, Giacco, GG, Hess, K, Larry, L, Rich, TA, Janjan, N,  et al. 1997p53 immunohistochemical staining predicts residual disease after chemoradiation in patients with high-risk rectal cancerClin Cancer Res3168590PubMedGoogle Scholar
  3. 3.
    Luna-Perez, P, Arriola, EL, Cuadra, Y, Alvarado, I, Quintero, A 1998p53 protein overexpression and response to induction chemoradiation therapy in patients with locally advanced rectal adenocarcinomaAnn Surg Oncol52038PubMedCrossRefGoogle Scholar
  4. 4.
    Tannapfel, A, Nusslein, S, Fietkau, R, Katalinic, A, Kockerling, F, Wittekind, C 1998Apoptosis, proliferation, bax, bcl-2 and p53 status prior to and after preoperative radiochemotherapy for locally advanced rectal cancerInt J Radiat Oncol Biol Phys4158591PubMedCrossRefGoogle Scholar
  5. 5.
    Elsaleh, H, Robbins, P, Joseph, D, Powell, B, Grieu, F, Menso, L,  et al. 2000Can p53 alterations be used to predict tumour response to pre-operative chemo-radiotherapy in locally advanced rectal cancer?Radiother Oncol5623944PubMedCrossRefGoogle Scholar
  6. 6.
    Kim, NK, Park, JK, Lee, KY, Yang, WI, Yun, SH, Sung, J,  et al. 2001p53, BCL-2, and Ki-67 expression according to tumor response after concurrent chemoradiotherapy for advanced rectal cancerAnn Surg Oncol841824PubMedCrossRefGoogle Scholar
  7. 7.
    Saw, RP, Morgan, M, Koorey, D, Painter, D, Findlay, M, Stevens, G,  et al. 2003p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapyDis Colon Rectum46192202PubMedCrossRefGoogle Scholar
  8. 8.
    Esposito, G, Pucciarelli, S, Alaggio, R, Giacomelli, L, Marchiori, E, Iaderosa, GA,  et al. 2001P27kip1 expression is associated with tumor response to preoperative chemoradiotherapy in rectal cancerAnn Surg Oncol83118PubMedCrossRefGoogle Scholar
  9. 9.
    Gunther, K, Dimmler, A, Rodel, F, Reulbach, U, Merkel, S, Bittorf, BR,  et al. 2003P27 does not predict histopathological response to radiochemotherapy in rectal cancerJ Surg Res11317988PubMedCrossRefGoogle Scholar
  10. 10.
    Staunton, JE, Slonim, DK, Coller, HA, Tamayo, P, Angelo, MJ, Park, J,  et al. 2001Chemosensitivity prediction by transcriptional profilingProc Natl Acad Sci USA981078792PubMedCrossRefGoogle Scholar
  11. 11.
    Scherf, U, Ross, DT, Waltham, M, Smith, LH, Lee, JK, Tanabe, L,  et al. 2000A gene expression database for the molecular pharmacology of cancerNat Genet2423644PubMedCrossRefGoogle Scholar
  12. 12.
    Matsuyama, A, Inoue, H, Shibuta, K, Tanaka, Y, Barnard, GF, Sugimachi, K,  et al. 2001Hepatoma-derived growth factor is associated with reduced sensitivity to irradiation in esophageal cancerCancer Res6157147PubMedGoogle Scholar
  13. 13.
    Kusunoki, M, Yanagi, H, Kamikonya, N, Noda, M, Yamamura, T 1996Significant effects of preoperative intraluminal brachytherapy on the survival rate after resection of rectal carcinomaInt J Oncol964551Google Scholar
  14. 14.
    Hughes, TR, Mao, M, Jones, AR, Burchard, J, Marton, MJ, Shannon, KW,  et al. 2001Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizerNat Biotechnol193427PubMedCrossRefGoogle Scholar
  15. 15.
    van ‘t Veer, LJ, Dai, H, van de Vijver, MJ, He, YD, Hart, AA, Mao, M,  et al. 2002Gene expression profiling predicts clinical outcome of breast cancerNature4155306PubMedCrossRefGoogle Scholar
  16. 16.
    Jenkins, ZA, Haag, PG, Johansson, HE 2001Human eIF5A2 on chromosome 3q25-q27 is a phylogenetically conserved vertebrate variant of eukaryotic translation initiation factor 5A with tissue-specific expressionGenomics711019PubMedCrossRefGoogle Scholar
  17. 17.
    Clement, PM, Henderson, CA, Jenkins, ZA, Smit-McBride, Z, Wolff, EC, Hershey, JW,  et al. 2003Identification and characterization of eukaryotic initiation factor 5A-2Eur J Biochem270425463PubMedCrossRefGoogle Scholar
  18. 18.
    Cao, D, Hustinx, SR, Sui, G, Bala, P, Sato, N, Martin, S,  et al. 2004Identification of novel highly expressed genes in pancreatic ductal adenocarcinomas through a bioinformatics analysis of expressed sequence tagsCancer Biol Ther310819PubMedCrossRefGoogle Scholar
  19. 19.
    Gerard, A, Buyse, M, Nordlinger, B, Loygue, J, Pene, F, Kempf, P,  et al. 1988Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC)Ann Surg20860614PubMedCrossRefGoogle Scholar
  20. 20.
    Swedish Rectal Cancer Trial1997Improved survival with preoperative radiotherapy in resectable rectal cancerN Engl J Med3369807CrossRefGoogle Scholar
  21. 21.
    Kapiteijn, E, Marijnen, CA, Nagtegaal, ID, Putter, H, Steup, WH, Wiggers, T,  et al. 2001Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancerN Engl J Med34563846PubMedCrossRefGoogle Scholar
  22. 22.
    Sauer, R Becker, H Hohenberger, W Rodel, C Wittekind, C Fietkau, R German Rectal Cancer Study Group et al. 2004Preoperative versus postoperative chemoradiotherapy for rectal cancerN Engl J Med351173140PubMedCrossRefGoogle Scholar
  23. 23.
    Li, AL, Li, HY, Jin, BF, Ye, QN, Zhou, T, Yu, XD,  et al. 2004A novel eIF5A complex functions as a regulator of p53 and p53-dependent apoptosisJ Biol Chem279492518PubMedCrossRefGoogle Scholar
  24. 24.
    Jiang, X, Kim, HE, Shu, H, Zhao, Y, Zhang, H, Kofron, J,  et al. 2003Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathwayScience2992236PubMedCrossRefGoogle Scholar
  25. 25.
    Dominguez, F, Magdalene, C, Cancio, E, Roson, E, Paredes, J, Loidi, L,  et al. 1993Tissue concentrations of prothymosin alpha: a novel proliferation index of primary breast cancerEur J Cancer29A8937PubMedCrossRefGoogle Scholar
  26. 26.
    Tsitsilonis, OE, Bekris, E, Voutsas, IF, Baxevanis, CN, Markopoulos, C, Papadopoulou, SA,  et al. 1998The prognostic value of alpha-thymosins in breast cancerAnticancer Res1815018PubMedGoogle Scholar
  27. 27.
    Magdalena, C, Dominguez, F, Loidi, L, Puente, JL 2000Tumour prothymosin alpha content, a potential prognostic marker for primary breast cancerBr J Cancer8258490PubMedCrossRefGoogle Scholar
  28. 28.
    Mori, M, Bernard, GF, Staniunas, RJ, Jessup, JM, Steele, GD,Jr, Chen, LB 1993Prothymosin–alpha mRNA expression correlate with that of c-myc in human colon cancerOncogene828216PubMedGoogle Scholar
  29. 29.
    Wu, CG, Habib, NA, Mitry, RR, Reitsma, PH, van Deventer, SJ, Chamuleau, RA 1997Overexpression of hepatic prothymosin alpha, a novel marker for human hepatocellular carcinomaBr J Cancer761199204PubMedGoogle Scholar
  30. 30.
    Sasaki, H, Nonaka, M, Fujii, Y, Yamakawa, Y, Fukai, I, Kiriyama, M,  et al. 2001Expression of the prothymosin-a gene as a prognostic factor in lung cancerSurg Today319368PubMedCrossRefGoogle Scholar
  31. 31.
    Giagkousiklidis, S, Vogler, M, Westhoff, MA, Kasperczyk, H, Debatin, KM, Fulda, S 2005Sensitization for gamma—irradiation—induced apoptosis by second mitochondria—derived activation of caspaseCancer Res651050213PubMedCrossRefGoogle Scholar
  32. 32.
    Belka, C, Jendrossek, V, Pruschy, M, Vink, S, Verheij, M, Budach, W 2004Apoptosis-modulating agents in combination with radiotherapy-current status and outlookInt J Radiat Oncol Biol Phys5854254PubMedCrossRefGoogle Scholar
  33. 33.
    Schmidt-Ullrich, RK, Dent, P, Grant, S, Mikkelsen, RB, Valerie, K 2000Signal transduction and cellular radiation responsesRadiat Res15324557PubMedCrossRefGoogle Scholar
  34. 34.
    Vousden, KH, Lu, X 2002Live or let die: the cell's response to p53Nat Rev Cancer2594604PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Tokyo 2007

Authors and Affiliations

  • Eiki Ojima
    • 1
  • Yasuhiro Inoue
    • 1
  • Chikao Miki
    • 1
  • Masaki Mori
    • 2
  • Masato Kusunoki
    • 1
  1. 1.Department of Gastrointestinal and Pediatric Surgery, Division of Reparative MedicineInstitute of Life Sciences, Mie University Graduate School of MedicineTsuJapan
  2. 2.Department of Surgery and Molecular Oncology, Medical Institute of BioregulationKyushu UniversityBeppuJapan

Personalised recommendations